Shuttle Pharmaceuticals dips 6%, prices $4.5M share offering

seekingalpha
2024-10-30
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) priced a public offering with a health-care focused institutional investor for the purchase and sale of up to ~2.95M shares and warrants to purchase up to ~2.95M shares at a combined offering price of $1.525 per share and accompanying warrant.
  • The aggregate gross proceeds of approximately $4.5M and assuming no exercise of the warrants. The warrants will have an exercise price of $1.40 per share.
  • The closing of the offering is expected to occur on or about October 31, 2024.
  • Net proceeds will be used to fund IND-enabling and Phase I and II clinical trials of product candidates, including $2.3M in payments that will be owed to Theradex Systems.
  • The stock price dropped 5.6% on Tuesday during after hours of trading.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10